Headlines

MID WEB AD_Vertical left side 426 pixels (height) x 170 pixels (width).gif

Semaglutide before bariatric surgery does not improve weight loss or safety, suggesting a ‘surgery-first strategy’ could lead to better outcomes

Total weight loss did not increase for patients who took semaglutide before having BMS, suggesting that a surgery-first strategy could...

Semaglutide before bariatric surgery does not improve weight loss or safety, suggesting a ‘surgery-first strategy’ could lead to better outcomes

Semaglutide before bariatric surgery does not improve weight loss or safety, suggesting a ‘surgery-first strategy’ could lead to better outcomes

Total weight loss did not increase for patients who took semaglutide before having BMS, suggesting that a surgery-first strategy could...

Semaglutide before bariatric surgery does not improve weight loss or safety, suggesting a ‘surgery-first strategy’ could lead to better outcomes

3.8 billion adults and 746 million children and adolescents predicted to have overweight or obesity by 2050

Only approved centres should be carrying bariatric medical tourism

Research

Genome-edited stem cells offer hope for obesity treatment without muscle loss

Researchers at the Beijing Institute of Stem Cells and Regeneration (BISCRM) and the Institute of Zoology (IOZ) have cracked the code of...

VIVUS launches QSYMIA in the UAE

VIVUS has received market approval of QSYMIA (phentermine and topiramate extended-release capsules) CIV in the United Arab Emirates (UAE)...

REDEFINE 2: CagriSema demonstrates superior weight loss

Outcomes from the from REDEFINE 2, a phase 3 trial in the global REDEFINE programme, have revealed the trial achieved its primary...

First patient dosed in the clinical study of bofanglutide injection for overweight or obesity

The first participant has been successfully dosed in Gan & Lee Pharmaceuticals’ Phase 2 clinical trial of bofanglutide (GZR18) injection,...

More than 65 organisations advocate for coverage of obesity care in open letter to leading employers as Obesity Care Week urges expanded coverage to include FDA-approved obesity medications

The Alliance for Women's Health and Prevention's (AWHP) EveryBODY Covered campaign delivered an open letter to executives at top...

Naturally occurring BRP molecule rivals semaglutide in weight loss but without side effects

Stanford University Medical Center researchers have identified a naturally occurring molecule, BRP, which appears similar to semaglutide...

Melatonin improves muscle energy efficiency offering a potential therapy to combat diabesity

An international study led by the University of Granada (UGR) has revealed that melatonin, known for its ability to regulate the...

The cause of leptin resistance and how to reverse it

Researchers at Rockefeller University have discovered a neural mechanism involved in leptin resistance and, crucially, a way to reverse...

Semaglutide before bariatric surgery does not improve weight loss or safety, suggesting a ‘surgery-first strategy’ could lead to better outcomes

Total weight loss did not increase for patients who took semaglutide before having BMS, suggesting that a surgery-first strategy could...

Journal Watch 5/3/2025

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

3.8 billion adults and 746 million children and adolescents predicted to have overweight or obesity by 2050

Without urgent policy reform and action, over half the world's adult population (3.8 billion) and a third of all children and adolescents...

The brain acts as a critical control centre into the origins of type 2 diabetes and obesity

A study by the University Hospital of Tübingen, the German Center for Diabetes Research (Deutsches Zentrum fuer Diabetesforschung, DZD),...

Industry

VIVUS launches QSYMIA in the UAE

The Obesity Society commends FDA's resolution of obesity drug shortages and calls for enforcement against unauthorised compounding

ReShape signs distribution agreement in Canada with Liaison Medical for its next-generation Lap-Band 2.0 FLEX

ANSM clears Allurion to resume sales of the Allurion Balloon in France

All caught up?

See all news

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Browse directory

Events

Headlines

Semaglutide before bariatric surgery does not improve weight loss or safety, suggesting a ‘surgery-first strategy’ could lead to better outcomes

Semaglutide before bariatric surgery does not improve weight loss or safety, suggesting a ‘surgery-first strategy’ could lead to better outcomes

Semaglutide before bariatric surgery does not improve weight loss or safety, suggesting a ‘surgery-first strategy’ could lead to better outcomes

3.8 billion adults and 746 million children and adolescents predicted to have overweight or obesity by 2050

Only approved centres should be carrying bariatric medical tourism

Research

Genome-edited stem cells offer hope for obesity treatment without muscle loss

VIVUS launches QSYMIA in the UAE

REDEFINE 2: CagriSema demonstrates superior weight loss

First patient dosed in the clinical study of bofanglutide injection for overweight or obesity

More than 65 organisations advocate for coverage of obesity care in open letter to leading employers as Obesity Care Week urges expanded coverage to include FDA-approved obesity medications

Naturally occurring BRP molecule rivals semaglutide in weight loss but without side effects

Melatonin improves muscle energy efficiency offering a potential therapy to combat diabesity

The cause of leptin resistance and how to reverse it

Semaglutide before bariatric surgery does not improve weight loss or safety, suggesting a ‘surgery-first strategy’ could lead to better outcomes

Journal Watch 5/3/2025

3.8 billion adults and 746 million children and adolescents predicted to have overweight or obesity by 2050

The brain acts as a critical control centre into the origins of type 2 diabetes and obesity

Industry

VIVUS launches QSYMIA in the UAE

The Obesity Society commends FDA's resolution of obesity drug shortages and calls for enforcement against unauthorised compounding

ReShape signs distribution agreement in Canada with Liaison Medical for its next-generation Lap-Band 2.0 FLEX

ANSM clears Allurion to resume sales of the Allurion Balloon in France

All caught up?

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Events

(See all)

6th London International Bariatric Surgery Symposium (LIBSS)

XXVIII IFSO World Congress

16th BOMSS Annual Scientific Meeting

Iberian Bariatric Surgery Course

Sixth IBC Oxford University World Congress 2025

9th IFSO-APC and 22nd OSSICON meeting

32nd European Congress on Obesity

13th Congress of IFSO-EC

3rd IFSO MENAC & 20th ESBS 2024 Meeting

Tweets

Back to Top